A multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of levetiracetam versus placebo for social anxiety disorder (generalized type)
Phase of Trial: Phase III
Latest Information Update: 02 Feb 2010
At a glance
- Drugs Levetiracetam (Primary)
- Indications Social phobia
- Focus Therapeutic Use
- 02 Feb 2010 Results published in the Journal of Clinical Psychiatry.
- 15 Dec 2009 Results were published in the Journal of Clinical Psychiatry.
- 15 Dec 2009 Primary endpoint 'Liebowitz Social Anxiety Scale' has not been met.